Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease
- Authors: LETO G; CRESCIMANNO M; FLANDINA C; TUMMINELLO FM; ARCARA C; BADALAMENTI G; GEBBIA N; VIZZINI L; FULFARO F
- Publication year: 2004
- Type: eedings
- OA Link: http://hdl.handle.net/10447/24436